Design, synthesis, and evaluation of purine and pyrimidine-based KRAS G12D inhibitors: Towards potential anticancer therapy

嘌呤 嘧啶 药理学 癌症研究 化学 医学 肿瘤科 立体化学 生物化学 酶
作者
S.L. Park,Venu Venkatarame Gowda Saralamma,Sagar D. Nale,Chang Joong Kim,Yun Seong Jo,Mohammad Hassan Baig,JungHwan Cho
出处
期刊:Heliyon [Elsevier BV]
卷期号:10 (7): e28495-e28495 被引量:7
标识
DOI:10.1016/j.heliyon.2024.e28495
摘要

Oncogenic RAS mutations, commonly observed in human tumors, affect approximately 30% of cancer cases and pose a significant challenge for effective cancer treatment. Current strategies to inhibit the KRAS G12D mutation have shown limited success, emphasizing the urgent need for new therapeutic approaches. In this study, we designed and synthesized several purine and pyrimidine analogs as inhibitors for the KRAS G12D mutation. Our synthesized compounds demonstrated potent anticancer activity against cell lines with the KRAS G12D mutation, effectively impeding their growth. They also exhibited low toxicity in normal cells, indicating their selective action against cancer cells harboring the KRAS G12D mutation. Notably, the lead compound, PU1-1 induced the programmed cell death of KRAS G12D-mutated cells and reduced the levels of active KRAS and its downstream signaling proteins. Moreover, PU1-1 significantly shrunk the tumor size in a pancreatic xenograft model induced by the KRAS G12D mutation, further validating its potential as a therapeutic agent. These findings highlight the potential of purine-based KRAS G12D inhibitors as candidates for targeted cancer therapy. However, further exploration and optimization of these compounds are essential to meet the unmet clinical needs of patients with KRAS -mutant cancers.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
凉白开发布了新的文献求助10
1秒前
深情安青的应助被苏道采纳,获得10
1秒前
2秒前
英吉利25发布了新的文献求助30
2秒前
3秒前
West发布了新的文献求助10
3秒前
阳光天磊发布了新的文献求助10
3秒前
秦风完成签到,获得积分10
3秒前
桐桐的应助被kissshot7采纳,获得10
4秒前
5秒前
ss发布了新的文献求助10
5秒前
5秒前
起司发布了新的文献求助60
5秒前
6秒前
6秒前
乐观铅笔发布了新的文献求助30
6秒前
6秒前
无限的含羞草完成签到,获得积分10
6秒前
研友_LpvQlZ完成签到,获得积分10
7秒前
共享精神的应助被陆羽采纳,获得10
8秒前
共享精神的应助被xxh采纳,获得10
8秒前
04d的应助被Samuel采纳,获得10
8秒前
wy关注了科研通微信公众号
9秒前
轻松幼荷完成签到,获得积分10
9秒前
coolru的应助被mooncake采纳,获得30
9秒前
星月发布了新的文献求助10
9秒前
10秒前
7777发布了新的文献求助10
10秒前
10秒前
11秒前
大里完成签到 ,获得积分10
11秒前
远远完成签到,获得积分10
11秒前
11秒前
12秒前
怡春院李老鸨的应助被麤七采纳,获得100
12秒前
12秒前
anna1992发布了新的文献求助10
12秒前
喜悦桥发布了新的文献求助10
12秒前
是奶柚啊发布了新的文献求助10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163614
求助须知:如何正确求助?哪些是违规求助? 9557702
关于积分的说明 21741573
捐赠科研通 7754282
什么是DOI,文献DOI怎么找? 3428275
关于科研通互助平台的介绍 2552989
邀请新用户注册赠送积分活动 2472923